SKYRIZI 150 MG/ML PEN

SKYRIZI 150 MG/ML PEN is a brand name prescription medication. It is tracked in the NADAC database with a current average price of $17,642.38 per per milliliter.

Based on NADAC (National Average Drug Acquisition Cost) data, SKYRIZI 150 MG/ML PEN has an average price of $17,642.38 per per milliliter. Prices range from $17,642.38 to $17,642.38. Actual retail prices may vary by pharmacy and location.

SKYRIZI 150 MG/ML PEN is a brand-name medication. Generic alternatives may be available at lower prices. Use our search to find generic equivalents with the same active ingredient. The FDA requires generics to have the same active ingredient, strength, dosage form, and route of administration as the brand-name drug.

Yes, Skyrizi On-Body (Risankizumab-Rzaa) is included in Medicare Part D spending data. In 2023, total Medicare spending on this drug was $125.3M. Medicare Part D plans may cover this medication, but coverage varies by plan. Check with your specific Part D plan for details.

All pricing data comes from the NADAC (National Average Drug Acquisition Cost) database published by the Centers for Medicare & Medicaid Services (CMS). Medicare spending data comes from the Medicare Part D Spending by Drug dataset. FDA drug details come from the National Drug Code Directory. All sources are official U.S. government data.

To reduce costs on SKYRIZI 150 MG/ML PEN: Ask your doctor about generic alternatives. Compare prices at different pharmacies. Check if your insurance or Medicare plan covers it. Look into patient assistance programs from the manufacturer. Consider mail-order pharmacies for maintenance medications. GoodRx and similar services may offer additional discounts.